| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.9M | -4.3% |
| Cost of Revenue | $6.6M | +8.6% |
| R&D Expense | $4.8M | -17.4% |
| SG&A Expense | $11.1M | +4.5% |
| Operating Income | -$6.4M | +32.7% |
| Interest Expense | $606K | -9.3% |
| Pre-tax Income | -$6.5M | -2.9% |
| Income Tax | -$23K | -149.5% |
| Net Income | -$6.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.0M | -2.0% |
| Accounts Receivable | $11.7M | +19.9% |
| Inventory | $4.0M | -13.2% |
| Current Assets | $36.5M | +2.1% |
| Total Assets | $75.6M | -7.6% |
| Current Liabilities | $31.6M | +13.0% |
| Total Liabilities | $53.0M | +1.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$612K | -110.0% |
| Capital Expenditures | $66K | -76.4% |
| Investing Cash Flow | $58K | +154.7% |
| Financing Cash Flow | $197K | +102.7% |
| Free Cash Flow | -$679K | -111.7% |
| -3.2% |
| EPS (Basic) | -$0.46 | -4.5% |
| EPS (Diluted) | -$0.46 | -4.5% |
| Stockholders' Equity |
| $22.9M |
| -22.8% |